{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:25:51Z","timestamp":1760027151087},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2002,10,1]]},"DOI":"10.1038\/sj.jhh.1001469","type":"journal-article","created":{"date-parts":[[2002,11,7]],"date-time":"2002-11-07T12:20:25Z","timestamp":1036671625000},"page":"691-697","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Are we negating the benefits of CABG by forgetting secondary prevention?"],"prefix":"10.1038","volume":"16","author":[{"given":"PR","family":"Belcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Gaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DJ","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GM","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,11,6]]},"reference":[{"key":"BF1001469_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1136\/heart.85.1.80","volume":"85","author":"GM Lindsay","year":"2001","unstructured":"Lindsay GM, Smith LN, Hanlon P, Wheatley DJ . The influence of general health status and social support on symptomatic outcome following coronary artery bypass grafting Heart 2001 85: 80\u201386","journal-title":"Heart"},{"key":"BF1001469_CR2","doi-asserted-by":"crossref","unstructured":"National Institute of Health Consensus. Development Conference Statement: coronary artery bypass surgery: scientific and clinical aspects N Engl J Med 1981 304: 680\u2013684","DOI":"10.1056\/NEJM198103123041134"},{"key":"BF1001469_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/bmj.306.6883.983","volume":"306","author":"P Sever","year":"1993","unstructured":"Sever P et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society Br Med J 1993 306: 983\u2013987","journal-title":"Br Med J"},{"key":"BF1001469_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/bmj.319.7210.630","volume":"319","author":"LE Ramsay","year":"1999","unstructured":"Ramsay LE et al. British Hypertension Society guidelines for hypertension management 1999: summary Br Med J 1999 319: 630\u2013635","journal-title":"Br Med J"},{"key":"BF1001469_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/080370599439571","volume":"8","author":"J Herlitz","year":"1999","unstructured":"Herlitz J et al. Mortality, risk indicators, mode and place of death and symptoms of angina pectoris in the five years after coronary bypass grafting in patients with and without a history of hypertension Blood Press 1999 8: 200\u2013206","journal-title":"Blood Press"},{"key":"BF1001469_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/00004872-199715090-00015","volume":"15","author":"H Sjoland","year":"1997","unstructured":"Sjoland H et al. Improvement in various estimates of quality of life after coronary artery bypass grafting in patients with and without a history of hypertension J Hypertens 1997 15: 1033\u20131039","journal-title":"J Hypertens"},{"key":"BF1001469_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/019394598901100111","volume":"11","author":"KA Kee","year":"1989","unstructured":"Kee KA, Kieckhefer GM . Measuring human responses using visual analog scales Western J Nurs Res 1989 11: 128\u2013132","journal-title":"Western J Nurs Res"},{"key":"BF1001469_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/01.CIR.52.3.369","volume":"52","author":"L Campeau","year":"1975","unstructured":"Campeau L . Grading of angina pectoris [Letter] Circulation 1975 52: 522","journal-title":"Circulation"},{"key":"BF1001469_CR9","unstructured":"Criteria Committee for the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Blood Vessels 7th Edn Little Brown and Company: Boston 1974"},{"key":"BF1001469_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0002-9343(84)90952-5","volume":"76","author":"WP Castelli","year":"1984","unstructured":"Castelli WP . Epidemiology of coronary heart disease: the Framingham study Am J Med 1984 76: (Suppl 2A) 4\u201312","journal-title":"Am J Med"},{"key":"BF1001469_CR11","doi-asserted-by":"crossref","unstructured":"CABRI Trial. Participants first-year results of CABRI (Coronary Angioplasty vs Bypass Revascularisation Investigation) Lancet 1995 346: 1179\u20131184","DOI":"10.1016\/S0140-6736(95)92896-0"},{"key":"BF1001469_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/01.CIR.94.2.135","volume":"94","author":"SJ Pocock","year":"1996","unstructured":"Pocock SJ et al. Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial Circulation 1996 94: 135\u2013142","journal-title":"Circulation"},{"key":"BF1001469_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/jech.39.3.197","volume":"39","author":"AG Shaper","year":"1985","unstructured":"Shaper AG et al. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study J Epidemiol Commun Health 1985 39: 197\u2013209","journal-title":"J Epidemiol Commun Health"},{"key":"BF1001469_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/08037059709062095","volume":"6","author":"I Wiklund","year":"1997","unstructured":"Wiklund I, Halling K, Ryden-Bergsten T, Fletcher A . Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study Blood Press 1997 6: 357\u2013364","journal-title":"Blood Press"},{"key":"BF1001469_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","volume":"335","author":"R Collins","year":"1990","unstructured":"Collins R et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 1990 335: 827\u2013838","journal-title":"Lancet"},{"key":"BF1001469_CR16","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 1998 351: 1755\u20131762","journal-title":"Lancet"},{"key":"BF1001469_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0002-9149(01)01730-1","volume":"88","author":"M Zabalgoitia","year":"2001","unstructured":"Zabalgoitia M et al. Effect of regression of left ventricular hypertrophy from systemic hypertension on systolic function assessed by midwall shortening (HOT echocardiographic study) Am J Cardiol 2001 88: 521\u2013525","journal-title":"Am J Cardiol"},{"key":"BF1001469_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s003920050060","volume":"86","author":"A Enbergs","year":"1997","unstructured":"Enbergs A et al. Secondary prevention of coronary heart disease: ideal versus reality in the Munster EURASPIRE study population Z Kardiol 1997 86: 284\u2013291","journal-title":"Z Kardiol"},{"key":"BF1001469_CR19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/bmj.322.7300.1463","volume":"322","author":"AJB Brady","year":"2001","unstructured":"Brady AJB, Oliver MA, Pittard JB . Secondary prevention in 24,431 patients with coronary heart disease: survey in primary care Br Med J 2001 322: 1463","journal-title":"Br Med J"},{"key":"BF1001469_CR20","doi-asserted-by":"crossref","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thrombo-embolism in atrial fibrillation: stroke prevention in atrial fibrillation II study Lancet 1994 343: 687\u2013691","DOI":"10.1016\/S0140-6736(94)91577-6"},{"key":"BF1001469_CR21","doi-asserted-by":"crossref","unstructured":"Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 1994 154: 1449\u20131457","DOI":"10.1001\/archinte.154.13.1449"},{"key":"BF1001469_CR22","doi-asserted-by":"crossref","unstructured":"Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 1994 344: 1383\u20131389","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"BF1001469_CR23","doi-asserted-by":"publisher","first-page":"29H","DOI":"10.1016\/S0002-9149(00)01097-3","volume":"86","author":"WV Brown","year":"2000","unstructured":"Brown WV . Cholesterol lowering in atherosclerosis Am J Cardiol 2000 86: (4B) 29H\u201332H","journal-title":"Am J Cardiol"},{"key":"BF1001469_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00019501-200106000-00006","volume":"12","author":"KK Koh","year":"2001","unstructured":"Koh KK et al. Non-lipid effects of statin on hyper-cholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet Coronary Artery Dis 2001 12: 305\u2013311","journal-title":"Coronary Artery Dis"},{"key":"BF1001469_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0735-1097(99)00145-X","volume":"34","author":"GC Flaker","year":"1999","unstructured":"Flaker GC et al. Pravastatin prevents clinical events in revascularised patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators J Am Coll Cardiol 1999 34: 106\u2013112","journal-title":"J Am Coll Cardiol"},{"key":"BF1001469_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0002-9149(89)90140-9","volume":"63","author":"DG Cook","year":"1989","unstructured":"Cook DG, Shaper AG . Breathlessness, angina pectoris and coronary artery disease Am J Cardiol 1989 63: 921\u2013924","journal-title":"Am J Cardiol"},{"key":"BF1001469_CR27","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0149-2918(96)80212-8","volume":"18","author":"S Oparil","year":"1996","unstructured":"Oparil S et al. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochloro-thiazide, versus amlodipine, alone or with hydrochloro-thiazide, in patients with essential hypertension Clin Ther 1996 18: 608\u2013625","journal-title":"Clin Ther"},{"key":"BF1001469_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/qjmed\/92.2.87","volume":"92","author":"JS Skinner","year":"1999","unstructured":"Skinner JS et al. Patient-related outcomes five years after coronary artery bypass graft surgery Q J Med 1999 92: 87\u201396","journal-title":"Q J Med"},{"key":"BF1001469_CR29","first-page":"1497","volume":"87","author":"E Delacretaz","year":"1998","unstructured":"Delacretaz E et al. Secondary prevention of ischemic heart disease after coronary revascularization Schweiz Runsch Med Prax 1998 87: 1497\u20131503","journal-title":"Schweiz Runsch Med Prax"},{"key":"BF1001469_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1445-5994.1989.tb00252.x","volume":"19","author":"B Oldenburg","year":"1989","unstructured":"Oldenburg B, Pierce J, Sicree R, Ross D . Coronary risk factor outcomes following coronary artery bypass surgery Aust NZ J Med 1989 19: 234\u2013240","journal-title":"Aust NZ J Med"},{"key":"BF1001469_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/heart.86.3.317","volume":"86","author":"F McHugh","year":"2001","unstructured":"McHugh F et al. Nurse-led shared care for patients on the waiting list for CABG: a randomised controlled trial Heart 2001 86: 317\u2013323","journal-title":"Heart"},{"key":"BF1001469_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/hrt.80.5.447","volume":"80","author":"NC Campbell","year":"1998","unstructured":"Campbell NC et al. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care Heart 1998 80: 447\u2013452","journal-title":"Heart"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001469","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T14:27:09Z","timestamp":1647527229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,1]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10,1]]}},"alternative-id":["BF1001469"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001469","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,1]]},"assertion":[{"value":"30 January 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2002","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2002","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2002","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}